DuPont de Nemours, Inc. (NYSE:DD) Receives $43.69 Consensus Target Price from Analysts

Shares of DuPont de Nemours, Inc. (NYSE:DD) have received a consensus recommendation of “Moderate Buy” from the fifteen brokerages that are covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and ten have issued a buy recommendation on the company. The average 1 year target price among brokers that have covered the stock in the last year is $43.6865.

DD has been the topic of several analyst reports. Citigroup increased their price target on shares of DuPont de Nemours from $38.90 to $47.00 and gave the stock a “buy” rating in a research note on Friday, November 7th. KeyCorp reduced their price objective on shares of DuPont de Nemours from $93.00 to $44.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. JPMorgan Chase & Co. cut their target price on shares of DuPont de Nemours from $104.00 to $48.00 and set an “overweight” rating for the company in a research report on Tuesday, November 11th. Wolfe Research decreased their target price on DuPont de Nemours from $87.00 to $39.00 and set an “outperform” rating for the company in a research note on Tuesday, November 4th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of DuPont de Nemours in a research report on Monday, December 22nd.

DuPont de Nemours Stock Up 0.5%

Shares of DuPont de Nemours stock opened at $41.29 on Thursday. The company has a market cap of $17.30 billion, a P/E ratio of -22.44, a P/E/G ratio of 2.37 and a beta of 1.10. DuPont de Nemours has a 1 year low of $22.50 and a 1 year high of $41.85. The company has a current ratio of 2.00, a quick ratio of 1.63 and a debt-to-equity ratio of 0.30. The stock has a 50-day moving average price of $38.65 and a 200 day moving average price of $33.77.

DuPont de Nemours (NYSE:DD) last released its earnings results on Monday, July 11th. The basic materials company reported $0.29 earnings per share (EPS) for the quarter. DuPont de Nemours had a negative net margin of 6.17% and a positive return on equity of 7.81%. The company had revenue of $3.02 billion during the quarter. As a group, analysts expect that DuPont de Nemours will post 4.38 EPS for the current fiscal year.

DuPont de Nemours Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 28th were given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Friday, November 28th. DuPont de Nemours’s dividend payout ratio (DPR) is -43.48%.

DuPont de Nemours announced that its Board of Directors has initiated a stock buyback plan on Thursday, November 6th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the basic materials company to reacquire up to 12.2% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Insider Activity at DuPont de Nemours

In other DuPont de Nemours news, SVP Erik T. Hoover sold 6,005 shares of the company’s stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $39.79, for a total transaction of $238,938.95. Following the sale, the senior vice president directly owned 112,101 shares of the company’s stock, valued at approximately $4,460,498.79. This represents a 5.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Lori Koch sold 9,011 shares of the firm’s stock in a transaction on Friday, November 28th. The shares were sold at an average price of $39.46, for a total value of $355,574.06. Following the sale, the chief executive officer directly owned 288,326 shares of the company’s stock, valued at $11,377,343.96. This represents a 3.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.61% of the company’s stock.

Institutional Trading of DuPont de Nemours

Several hedge funds have recently modified their holdings of DD. Princeton Global Asset Management LLC increased its stake in shares of DuPont de Nemours by 64.4% in the 2nd quarter. Princeton Global Asset Management LLC now owns 365 shares of the basic materials company’s stock valued at $25,000 after buying an additional 143 shares during the period. Salomon & Ludwin LLC boosted its stake in DuPont de Nemours by 186.5% in the third quarter. Salomon & Ludwin LLC now owns 318 shares of the basic materials company’s stock valued at $25,000 after acquiring an additional 207 shares during the last quarter. Palisade Asset Management LLC acquired a new position in shares of DuPont de Nemours in the 3rd quarter valued at $26,000. Financial Life Planners acquired a new stake in shares of DuPont de Nemours during the third quarter worth $27,000. Finally, Imprint Wealth LLC bought a new position in DuPont de Nemours during the third quarter worth about $27,000. 73.96% of the stock is owned by institutional investors.

About DuPont de Nemours

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.